1109284-41-4

Basic information

• Product Name: tert-butyl (1R,2S)-3,3-difluoro-2-hydroxycyclohexylcarbamate
• CAS NO: 1109284-41-4
• Molecular Weight: 251.274
• Mol File: 1109284-41-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: tert-butyl (1R,2S)-3,3-difluoro-2-hydroxycyclohexylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (1R,2S)-3,3-difluoro-2-hydroxycyclohexylcarbamate(1109284-41-4)
• EPA Substance Registry System: tert-butyl (1R,2S)-3,3-difluoro-2-hydroxycyclohexylcarbamate(1109284-41-4)

Safety Data

• Hazardous Substances Data: 1109284-41-4(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 1109284-39-0 (1S,6R)-2,2-difluoro-6-[[(1R)-1-phenylethyl]amino]cyclohexanol 
• 6705-49-3 7-oxabicyclo[4.1.0]heptan-2-one 
• 1109284-40-3 (1S,6R)-6-amino-2,2-difluorocyclohexan-1-ol 
• 1109284-38-9 2,2-difluoro-7-oxabicyclo[4.1.0]heptane 
• 6705-49-3 7-oxabicyclo[4.1.0]heptan-2-one 

Downstream Products

• 1207557-06-9 (1S,6R)-6-((tert-butoxycarbonyl)amino)-2,2-difluorocyclohexyl trifluoromethanesulfonate 
• 1439907-22-8 2-((1R,2R)-2-amino-3,3-difluorocyclohexylamino)-4-(quinolin-3-ylamino)pyrimidin-5-carboxamide 
• 1109284-37-8 tert-butyl N-[(1R,2R)-2-amino-3,3-difluorocyclohexyl]carbamate 
• 1439905-72-2 4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-((1R,2R)-2-amino-3,3-difluorocyclohexylamino)pyrimidin-5-carboxamide 
• 1314893-26-9 N-((1R,6R)-6-amino-2,2-difluorocyclohexyl)-4-(6-chloropyrazolo[1,5-a]pyrimidin-3-yl)-5-methylthiophene-2-carboxamide 
• 1109284-45-8 tert-butyl N-[(1R,2R)-2-azido-3,3-difluorocyclohexyl]carbamate 

Relevant articles and documents

IRAK DEGRADERS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

SELECTIVE KINASE INHIBITORS

Provided are pyrimidine compounds for inhibiting of Syk kinase, intermediates used in making such compounds, methods for their preparation, pharmaceutical compositions thereof, methods for inhibition Syk kinase activity, and methods for treating conditions mediated at least in part by Syk kinase activity.

IMIDAZO[1,2-a]PYRIDINES AND IMIDAZO[1,2-b]PYRIDAZINES AS MARK INHIBITORS

The invention encompasses imidazo[1,2-a]pyridine and imidazo[1,2-b]pyridazine derivatives which selectively inhibit microtubule affinity regulating kinase (MARK) and are therefore useful for the treatment or prevention of Alzheimer's disease. Pharmaceutical compositions and methods of use are also included.